{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "cd498a91-563f-4495-91d4-2c2a789157c1",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "df=pd.read_excel(\"usecase_4_.xlsx\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "5ab9a89d-9c09-4c96-9d22-243a99688af4",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['NCT Number', 'Study Title', 'Study URL', 'Study Status',\n",
       "       'Brief Summary', 'Study Results', 'Conditions', 'Interventions',\n",
       "       'Primary Outcome Measures', 'Secondary Outcome Measures',\n",
       "       'Other Outcome Measures', 'Sponsor', 'Collaborators', 'Sex', 'Age',\n",
       "       'Phases', 'Enrollment', 'Funder Type', 'Study Type', 'Study Design',\n",
       "       'Other IDs', 'Start Date', 'Primary Completion Date', 'Completion Date',\n",
       "       'First Posted', 'Results First Posted', 'Last Update Posted',\n",
       "       'Locations', 'Study Recruitment Rate'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "37b4e939-0a98-41ff-92c3-5853355f0cc9",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCT Number                            object\n",
      "Study Title                           object\n",
      "Study URL                             object\n",
      "Study Status                          object\n",
      "Brief Summary                         object\n",
      "Study Results                         object\n",
      "Conditions                            object\n",
      "Interventions                         object\n",
      "Primary Outcome Measures              object\n",
      "Secondary Outcome Measures            object\n",
      "Other Outcome Measures                object\n",
      "Sponsor                               object\n",
      "Collaborators                         object\n",
      "Sex                                   object\n",
      "Age                                   object\n",
      "Phases                                object\n",
      "Enrollment                             int64\n",
      "Funder Type                           object\n",
      "Study Type                            object\n",
      "Study Design                          object\n",
      "Other IDs                             object\n",
      "Start Date                    datetime64[ns]\n",
      "Primary Completion Date               object\n",
      "Completion Date               datetime64[ns]\n",
      "First Posted                  datetime64[ns]\n",
      "Results First Posted          datetime64[ns]\n",
      "Last Update Posted            datetime64[ns]\n",
      "Locations                             object\n",
      "Study Recruitment Rate               float64\n",
      "dtype: object\n"
     ]
    }
   ],
   "source": [
    "print(df.dtypes)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "ff51d8df-f061-485b-9377-c33799f82952",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<bound method DataFrame.info of         NCT Number                                        Study Title  \\\n",
       "0      NCT00900809  QUILT-3.018: Neukoplastâ„¢ (NK-92) for the Tre...   \n",
       "1      NCT01113515  Clinical Investigation of GalnobaxÂ® for the T...   \n",
       "2      NCT01288573  A Combined Study in Pediatric Cancer Patients ...   \n",
       "3      NCT01336660  A Trial of Equine F (ab')2 Antivenom for Treat...   \n",
       "4      NCT01376167  Ph 2B/3 Tafenoquine (TFQ) Study in Prevention ...   \n",
       "...            ...                                                ...   \n",
       "20671  NCT04883333  A Single and Multiple Ascending-dose Trial of ...   \n",
       "20672  NCT02453087  A Study of Escalating Doses of DCDS0780A in Pa...   \n",
       "20673  NCT03850587  Clinical Trial of YYC301 for Treatment of Oste...   \n",
       "20674  NCT01981187   LGX818 for Patients With BRAFV600 Mutated Tumors   \n",
       "20675  NCT03591887  A Study to Evaluate ABY-035 in Subjects With M...   \n",
       "\n",
       "                                          Study URL Study Status  \\\n",
       "0      https://clinicaltrials.gov/study/NCT00900809    COMPLETED   \n",
       "1      https://clinicaltrials.gov/study/NCT01113515    COMPLETED   \n",
       "2      https://clinicaltrials.gov/study/NCT01288573    COMPLETED   \n",
       "3      https://clinicaltrials.gov/study/NCT01336660    COMPLETED   \n",
       "4      https://clinicaltrials.gov/study/NCT01376167    COMPLETED   \n",
       "...                                             ...          ...   \n",
       "20671  https://clinicaltrials.gov/study/NCT04883333    COMPLETED   \n",
       "20672  https://clinicaltrials.gov/study/NCT02453087    COMPLETED   \n",
       "20673  https://clinicaltrials.gov/study/NCT03850587    COMPLETED   \n",
       "20674  https://clinicaltrials.gov/study/NCT01981187   TERMINATED   \n",
       "20675  https://clinicaltrials.gov/study/NCT03591887    COMPLETED   \n",
       "\n",
       "                                           Brief Summary Study Results  \\\n",
       "0      NK cells from patients with malignant diseases...            NO   \n",
       "1      The purpose of this study is to determine safe...           YES   \n",
       "2      This is a multi-site study with plerixafor in ...            NO   \n",
       "3      This study has the objective to demonstrate th...            NO   \n",
       "4      The purpose of this two part study is to test ...           YES   \n",
       "...                                                  ...           ...   \n",
       "20671  This is a first-in-human study in adult health...            NO   \n",
       "20672  This open-label, multicenter, Phase 1/1b study...            NO   \n",
       "20673  A Multi-center, Double-blinded, Randomized, Ac...            NO   \n",
       "20674  The purpose of this signal seeking study is to...           YES   \n",
       "20675  This randomized, double-blinded dose-finding s...            NO   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                                 Acute Myeloid Leukemia   \n",
       "1                                    Diabetic Foot Ulcer   \n",
       "2      Ewing's Sarcoma/Soft Tissue Sarcoma|Neuroblast...   \n",
       "3                            Poisoning by Scorpion Sting   \n",
       "4                                         Malaria, Vivax   \n",
       "...                                                  ...   \n",
       "20671                                 Healthy Volunteers   \n",
       "20672                             Non-Hodgkin's Lymphoma   \n",
       "20673                               Osteoarthritis, Knee   \n",
       "20674               Solid Tumor|Hematologic Malignancies   \n",
       "20675                                   Plaque Psoriasis   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                      BIOLOGICAL: Neukoplastâ„¢ (NK-92)   \n",
       "1      DRUG: Esmolol hydrochloride|DRUG: Esmolol hydr...   \n",
       "2      DRUG: plerixafor|DRUG: plerixafor|DRUG: plerix...   \n",
       "3      BIOLOGICAL: Equine F(ab')2 antivenom|OTHER: In...   \n",
       "4      DRUG: Chloroquine 600mg|DRUG: Chloroquine 300m...   \n",
       "...                                                  ...   \n",
       "20671                     DRUG: LEO 153339|DRUG: Placebo   \n",
       "20672  DRUG: DCDS0780A|DRUG: Rituximab|DRUG: Obinutuz...   \n",
       "20673  DRUG: Celecoxib 200mg|DRUG: Tramadol 37.5Mg+ C...   \n",
       "20674                                       DRUG: LGX818   \n",
       "20675            BIOLOGICAL: ABY-035|BIOLOGICAL: Placebo   \n",
       "\n",
       "                                Primary Outcome Measures  \\\n",
       "0      Determine the safety / maximum tolerated dose ...   \n",
       "1      Safety Outcome, Number of participant with adv...   \n",
       "2      Proportion of patients achieving at least a do...   \n",
       "3      To demonstrate the effectiveness of Alacramyn ...   \n",
       "4      Number of Participants With Recurrence-free Ef...   \n",
       "...                                                  ...   \n",
       "20671  Number of treatment-emergent adverse events pe...   \n",
       "20672  Number of Participants with Adverse Events, Ba...   \n",
       "20673  100mm Pain VAS, Subjects who have severe pain ...   \n",
       "20674  Clinical Benefit Rate (CBR) for Solid Tumors a...   \n",
       "20675  Proportion of subjects with a â‰¥90% improveme...   \n",
       "\n",
       "                              Secondary Outcome Measures  ...  \\\n",
       "0      Evaluate the therapeutic efficacy of Neukoplas...  ...   \n",
       "1      Efficacy Outcome, To evaluate the percent chan...  ...   \n",
       "2      Number of days of apheresis required to reach ...  ...   \n",
       "3      Effectiveness of Alacramyn NAMO in the treatme...  ...   \n",
       "4      Number of Participants With Recurrence-free Ef...  ...   \n",
       "...                                                  ...  ...   \n",
       "20671  Plasma concentration of LEO 153339 and LEO 159...  ...   \n",
       "20672  Area Under the Serum Concentration-Time Curve ...  ...   \n",
       "20673                                                NaN  ...   \n",
       "20674  Overall Response Rate (ORR) for Solid Tumors a...  ...   \n",
       "20675  Number of treatment emergent Adverse Events, A...  ...   \n",
       "\n",
       "                                            Study Design  \\\n",
       "0      Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "1      Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "2      Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3      Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4      Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "...                                                  ...   \n",
       "20671  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "20672  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "20673  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "20674  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "20675  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "                                        Other IDs Start Date  \\\n",
       "0                                     QUILT-3.018 2014-05-12   \n",
       "1                          Novalead-Galnobax-0210 2014-02-20   \n",
       "2                DFI12860|2010-019340-40|MOZ15609 2014-03-03   \n",
       "3                                        XM-10/02 2018-07-21   \n",
       "4                                112582|TAF112582 2014-04-24   \n",
       "...                                           ...        ...   \n",
       "20671  LP0200-1495|2020-005748-51|U1111-1283-2001 2021-05-17   \n",
       "20672                                     GO29687 2015-08-04   \n",
       "20673                             YYPCT_YYC301_P2 2018-08-30   \n",
       "20674                       CLGX818AUS03|C4221021 2014-01-14   \n",
       "20675                  ABY-035-002|2017-001615-36 2018-03-07   \n",
       "\n",
       "      Primary Completion Date Completion Date First Posted  \\\n",
       "0         2015-06-02 00:00:00      2015-06-02   2009-05-13   \n",
       "1         2015-06-27 00:00:00      2015-10-17   2010-04-30   \n",
       "2         2017-05-09 00:00:00      2017-05-09   2011-02-02   \n",
       "3         2018-11-01 00:00:00      2018-11-15   2011-04-18   \n",
       "4         2016-11-18 00:00:00      2016-11-18   2011-06-20   \n",
       "...                       ...             ...          ...   \n",
       "20671     2022-07-18 00:00:00      2022-07-18   2021-05-12   \n",
       "20672     2019-07-12 00:00:00      2019-07-12   2015-05-25   \n",
       "20673     2020-05-12 00:00:00      2020-09-07   2019-02-22   \n",
       "20674     2015-09-01 00:00:00      2015-10-13   2013-11-11   \n",
       "20675     2019-03-27 00:00:00      2021-12-03   2018-07-19   \n",
       "\n",
       "       Results First Posted Last Update Posted  \\\n",
       "0                       NaT         2022-04-05   \n",
       "1                2024-05-20         2024-05-20   \n",
       "2                       NaT         2017-05-16   \n",
       "3                       NaT         2018-12-13   \n",
       "4                2018-04-23         2018-04-23   \n",
       "...                     ...                ...   \n",
       "20671                   NaT         2023-04-26   \n",
       "20672                   NaT         2019-08-29   \n",
       "20673                   NaT         2021-05-11   \n",
       "20674            2021-03-26         2021-03-26   \n",
       "20675                   NaT         2023-06-08   \n",
       "\n",
       "                                               Locations  \\\n",
       "0      UPMC Cancer Center - Hillman Cancer Center, Pi...   \n",
       "1      VA New England Health Care Division, Providenc...   \n",
       "2      Investigational Site Number 51, Gent, 9000, Be...   \n",
       "3      CHU Hassan II de FÃ¨s, FÃ¨s, Morocco|HÃ´pital ...   \n",
       "4      GSK Investigational Site, Bandarban, Banglades...   \n",
       "...                                                  ...   \n",
       "20671  LEO Pharma Investigational Site, Groningen, NZ...   \n",
       "20672  City of Hope National Medical Center, Duarte, ...   \n",
       "20673  Dong-A University Hospital., Busan, Korea, Rep...   \n",
       "20674  Alabama Oncology St. Vincent's Birmingham, Bir...   \n",
       "20675  Rothhaar Studien GmbH, Berlin, 10783, Germany|...   \n",
       "\n",
       "      Study Recruitment Rate  \n",
       "0                   0.551598  \n",
       "1                   0.443157  \n",
       "2                   0.044558  \n",
       "3                   7.279202  \n",
       "4                   1.969008  \n",
       "...                      ...  \n",
       "20671               7.693208  \n",
       "20672               0.199434  \n",
       "20673               1.074256  \n",
       "20674               0.044077  \n",
       "20675               0.133504  \n",
       "\n",
       "[20676 rows x 29 columns]>"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "dd3c886d-d6e8-408c-9797-886f441de57d",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "General Info:\n",
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 20676 entries, 0 to 20675\n",
      "Data columns (total 29 columns):\n",
      " #   Column                      Non-Null Count  Dtype         \n",
      "---  ------                      --------------  -----         \n",
      " 0   NCT Number                  20676 non-null  object        \n",
      " 1   Study Title                 20676 non-null  object        \n",
      " 2   Study URL                   20676 non-null  object        \n",
      " 3   Study Status                20676 non-null  object        \n",
      " 4   Brief Summary               20676 non-null  object        \n",
      " 5   Study Results               20676 non-null  object        \n",
      " 6   Conditions                  20676 non-null  object        \n",
      " 7   Interventions               20676 non-null  object        \n",
      " 8   Primary Outcome Measures    20676 non-null  object        \n",
      " 9   Secondary Outcome Measures  17757 non-null  object        \n",
      " 10  Other Outcome Measures      1729 non-null   object        \n",
      " 11  Sponsor                     20676 non-null  object        \n",
      " 12  Collaborators               5819 non-null   object        \n",
      " 13  Sex                         20670 non-null  object        \n",
      " 14  Age                         20676 non-null  object        \n",
      " 15  Phases                      20676 non-null  object        \n",
      " 16  Enrollment                  20676 non-null  int64         \n",
      " 17  Funder Type                 20676 non-null  object        \n",
      " 18  Study Type                  20676 non-null  object        \n",
      " 19  Study Design                20676 non-null  object        \n",
      " 20  Other IDs                   20676 non-null  object        \n",
      " 21  Start Date                  20676 non-null  datetime64[ns]\n",
      " 22  Primary Completion Date     20676 non-null  object        \n",
      " 23  Completion Date             20675 non-null  datetime64[ns]\n",
      " 24  First Posted                20676 non-null  datetime64[ns]\n",
      " 25  Results First Posted        7674 non-null   datetime64[ns]\n",
      " 26  Last Update Posted          20676 non-null  datetime64[ns]\n",
      " 27  Locations                   20676 non-null  object        \n",
      " 28  Study Recruitment Rate      20676 non-null  float64       \n",
      "dtypes: datetime64[ns](5), float64(1), int64(1), object(22)\n",
      "memory usage: 4.6+ MB\n",
      "None\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Descriptive Statistics for Numerical Columns:\n",
      "          Enrollment                     Start Date  \\\n",
      "count   20676.000000                          20676   \n",
      "mean      235.291159  2019-03-27 03:23:26.152060416   \n",
      "min         1.000000            2014-01-01 00:00:00   \n",
      "25%        23.000000            2017-06-30 00:00:00   \n",
      "50%        48.000000            2019-03-28 00:00:00   \n",
      "75%       135.000000            2021-03-01 00:00:00   \n",
      "max    477102.000000            2024-05-15 00:00:00   \n",
      "std      3534.300168                            NaN   \n",
      "\n",
      "                     Completion Date                   First Posted  \\\n",
      "count                          20675                          20676   \n",
      "mean   2021-02-13 16:53:23.869407488  2019-03-31 11:39:39.802669568   \n",
      "min              2014-02-08 00:00:00            2009-05-13 00:00:00   \n",
      "25%              2019-06-18 00:00:00            2017-06-08 00:00:00   \n",
      "50%              2021-06-17 00:00:00            2019-04-05 00:00:00   \n",
      "75%              2023-01-04 00:00:00            2021-03-11 06:00:00   \n",
      "max              2024-06-30 00:00:00            2024-11-25 00:00:00   \n",
      "std                              NaN                            NaN   \n",
      "\n",
      "                Results First Posted             Last Update Posted  \\\n",
      "count                           7674                          20676   \n",
      "mean   2021-11-23 03:52:29.648162560  2022-03-28 04:57:06.581543680   \n",
      "min              2015-01-14 00:00:00            2017-01-23 00:00:00   \n",
      "25%              2020-04-30 00:00:00            2020-11-08 06:00:00   \n",
      "50%              2022-01-08 00:00:00            2022-08-09 00:00:00   \n",
      "75%              2023-09-14 00:00:00            2023-12-11 00:00:00   \n",
      "max              2024-11-26 00:00:00            2024-11-26 00:00:00   \n",
      "std                              NaN                            NaN   \n",
      "\n",
      "       Study Recruitment Rate  \n",
      "count            20676.000000  \n",
      "mean                 6.680254  \n",
      "min                  0.001128  \n",
      "25%                  0.169638  \n",
      "50%                  0.829898  \n",
      "75%                  5.249065  \n",
      "max               4816.602871  \n",
      "std                 47.610877  \n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Frequency of Categorical Columns:\n",
      "Frequency of values in 'Allocation':\n"
     ]
    },
    {
     "ename": "KeyError",
     "evalue": "'Allocation'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "File \u001b[0;32m~/anaconda3/lib/python3.11/site-packages/pandas/core/indexes/base.py:3791\u001b[0m, in \u001b[0;36mIndex.get_loc\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m   3790\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m-> 3791\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_engine\u001b[38;5;241m.\u001b[39mget_loc(casted_key)\n\u001b[1;32m   3792\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m err:\n",
      "File \u001b[0;32mindex.pyx:152\u001b[0m, in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mindex.pyx:181\u001b[0m, in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mpandas/_libs/hashtable_class_helper.pxi:7080\u001b[0m, in \u001b[0;36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mpandas/_libs/hashtable_class_helper.pxi:7088\u001b[0m, in \u001b[0;36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[0;34m()\u001b[0m\n",
      "\u001b[0;31mKeyError\u001b[0m: 'Allocation'",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[5], line 16\u001b[0m\n\u001b[1;32m     14\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m col \u001b[38;5;129;01min\u001b[39;00m categorical_columns:\n\u001b[1;32m     15\u001b[0m     \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mFrequency of values in \u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mcol\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124m:\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m---> 16\u001b[0m     \u001b[38;5;28mprint\u001b[39m(df[col]\u001b[38;5;241m.\u001b[39mvalue_counts())\n\u001b[1;32m     17\u001b[0m     \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m+\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m-\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;241m*\u001b[39m\u001b[38;5;241m50\u001b[39m \u001b[38;5;241m+\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m     19\u001b[0m \u001b[38;5;66;03m# 4. Checking for Missing Values\u001b[39;00m\n",
      "File \u001b[0;32m~/anaconda3/lib/python3.11/site-packages/pandas/core/frame.py:3893\u001b[0m, in \u001b[0;36mDataFrame.__getitem__\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m   3891\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mcolumns\u001b[38;5;241m.\u001b[39mnlevels \u001b[38;5;241m>\u001b[39m \u001b[38;5;241m1\u001b[39m:\n\u001b[1;32m   3892\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_getitem_multilevel(key)\n\u001b[0;32m-> 3893\u001b[0m indexer \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mcolumns\u001b[38;5;241m.\u001b[39mget_loc(key)\n\u001b[1;32m   3894\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m is_integer(indexer):\n\u001b[1;32m   3895\u001b[0m     indexer \u001b[38;5;241m=\u001b[39m [indexer]\n",
      "File \u001b[0;32m~/anaconda3/lib/python3.11/site-packages/pandas/core/indexes/base.py:3798\u001b[0m, in \u001b[0;36mIndex.get_loc\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m   3793\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(casted_key, \u001b[38;5;28mslice\u001b[39m) \u001b[38;5;129;01mor\u001b[39;00m (\n\u001b[1;32m   3794\u001b[0m         \u001b[38;5;28misinstance\u001b[39m(casted_key, abc\u001b[38;5;241m.\u001b[39mIterable)\n\u001b[1;32m   3795\u001b[0m         \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;28many\u001b[39m(\u001b[38;5;28misinstance\u001b[39m(x, \u001b[38;5;28mslice\u001b[39m) \u001b[38;5;28;01mfor\u001b[39;00m x \u001b[38;5;129;01min\u001b[39;00m casted_key)\n\u001b[1;32m   3796\u001b[0m     ):\n\u001b[1;32m   3797\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m InvalidIndexError(key)\n\u001b[0;32m-> 3798\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m(key) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01merr\u001b[39;00m\n\u001b[1;32m   3799\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mTypeError\u001b[39;00m:\n\u001b[1;32m   3800\u001b[0m     \u001b[38;5;66;03m# If we have a listlike key, _check_indexing_error will raise\u001b[39;00m\n\u001b[1;32m   3801\u001b[0m     \u001b[38;5;66;03m#  InvalidIndexError. Otherwise we fall through and re-raise\u001b[39;00m\n\u001b[1;32m   3802\u001b[0m     \u001b[38;5;66;03m#  the TypeError.\u001b[39;00m\n\u001b[1;32m   3803\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_check_indexing_error(key)\n",
      "\u001b[0;31mKeyError\u001b[0m: 'Allocation'"
     ]
    }
   ],
   "source": [
    "# 1. General DataFrame Information\n",
    "print(\"General Info:\")\n",
    "print(df.info())  # Data types and non-null counts\n",
    "print(\"\\n\" + \"-\"*50 + \"\\n\")\n",
    "\n",
    "# 2. Basic Descriptive Statistics for Numerical Columns\n",
    "print(\"Descriptive Statistics for Numerical Columns:\")\n",
    "print(df.describe())  # Summary statistics for numerical columns\n",
    "print(\"\\n\" + \"-\"*50 + \"\\n\")\n",
    "\n",
    "# 3. Frequency Counts for Categorical Columns\n",
    "print(\"Frequency of Categorical Columns:\")\n",
    "categorical_columns = [\"Allocation\", \"Intervention Model\", \"Masking\", \"Primary Purpose\"]  # Add more categorical columns if needed\n",
    "for col in categorical_columns:\n",
    "    print(f\"Frequency of values in '{col}':\")\n",
    "    print(df[col].value_counts())\n",
    "    print(\"\\n\" + \"-\"*50 + \"\\n\")\n",
    "\n",
    "# 4. Checking for Missing Values\n",
    "print(\"Missing Values in Each Column:\")\n",
    "print(df.isnull().sum())  # Number of missing values in each column\n",
    "print(\"\\n\" + \"-\"*50 + \"\\n\")\n",
    "\n",
    "# 5. Correlation Matrix for Numerical Columns\n",
    "print(\"Correlation Matrix:\")\n",
    "correlation_matrix = df.corr()  # Correlation matrix for numerical columns\n",
    "print(correlation_matrix)\n",
    "print(\"\\n\" + \"-\"*50 + \"\\n\")\n",
    "\n",
    "# 6. Checking for Duplicates\n",
    "print(\"Number of Duplicate Rows:\")\n",
    "print(df.duplicated().sum())  # Number of duplicate rows in the DataFrame\n",
    "print(\"\\n\" + \"-\"*50 + \"\\n\")\n",
    "\n",
    "# 7. Unique Values in Columns\n",
    "print(\"Unique Values in Columns:\")\n",
    "for col in df.columns:\n",
    "    print(f\"Unique values in '{col}': {df[col].nunique()}\")\n",
    "    print(\"\\n\" + \"-\"*50 + \"\\n\")\n",
    "\n",
    "# 8. Skewness of Numerical Columns\n",
    "print(\"Skewness of Numerical Columns:\")\n",
    "print(df.skew())  # Skewness of the numerical columns\n",
    "print(\"\\n\" + \"-\"*50 + \"\\n\")\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "1459b291-6969-4e48-bd28-c75bde3be1a0",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop(['Collaborators', 'Study Title', 'Study URL', 'Brief Summary', \n",
    "              'Primary Outcome Measures', 'Secondary Outcome Measures', \n",
    "              'Other Outcome Measures', 'Other IDs','Primary Completion Date', \n",
    "              'First Posted', 'Results First Posted'], axis=1)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "bbca82cc-037a-4e23-ab29-5a600cf14464",
   "metadata": {},
   "outputs": [],
   "source": [
    "object_cols = df.select_dtypes(include='object').columns.tolist()\n",
    "int_cols = df.select_dtypes(include='int64').columns.tolist()\n",
    "float_cols = df.select_dtypes(include='float64').columns.tolist()\n",
    "datetime_cols = df.select_dtypes(include='datetime64[ns]').columns.tolist()\n",
    "\n",
    "# Combine into a dictionary for easier indexing\n",
    "column_groups = {\n",
    "    'object': object_cols,\n",
    "    'int': int_cols,\n",
    "    'float': float_cols,\n",
    "    'datetime': datetime_cols\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "1e396f35-5737-4243-8f27-3d4354ac27ac",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['NCT Number',\n",
       " 'Study Status',\n",
       " 'Study Results',\n",
       " 'Conditions',\n",
       " 'Interventions',\n",
       " 'Sponsor',\n",
       " 'Sex',\n",
       " 'Age',\n",
       " 'Phases',\n",
       " 'Funder Type',\n",
       " 'Study Type',\n",
       " 'Study Design',\n",
       " 'Locations']"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "object_cols"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "de12f8e8-858a-4ca0-8694-08eb798dfecd",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "\n",
    "df[['Allocation', 'Intervention Model', 'Masking', 'Primary Purpose']] = df['Study Design'].str.split('|', expand=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "67700b13-7792-46e4-8dd1-cb0daaa1a539",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Recruitment Rate</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>Intervention Model</th>\n",
       "      <th>Masking</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00900809</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Acute Myeloid Leukemia</td>\n",
       "      <td>BIOLOGICAL: Neukoplastâ„¢ (NK-92)</td>\n",
       "      <td>ImmunityBio, Inc.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>7</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2014-05-12</td>\n",
       "      <td>2015-06-02</td>\n",
       "      <td>2022-04-05</td>\n",
       "      <td>UPMC Cancer Center - Hillman Cancer Center, Pi...</td>\n",
       "      <td>0.551598</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>NONE</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01113515</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Diabetic Foot Ulcer</td>\n",
       "      <td>DRUG: Esmolol hydrochloride|DRUG: Esmolol hydr...</td>\n",
       "      <td>Novalead Pharma Private Limited</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1|PHASE2</td>\n",
       "      <td>44</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-02-20</td>\n",
       "      <td>2015-10-17</td>\n",
       "      <td>2024-05-20</td>\n",
       "      <td>VA New England Health Care Division, Providenc...</td>\n",
       "      <td>0.443157</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01288573</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Ewing's Sarcoma/Soft Tissue Sarcoma|Neuroblast...</td>\n",
       "      <td>DRUG: plerixafor|DRUG: plerixafor|DRUG: plerix...</td>\n",
       "      <td>Genzyme, a Sanofi Company</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>PHASE1|PHASE2</td>\n",
       "      <td>46</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-03-03</td>\n",
       "      <td>2017-05-09</td>\n",
       "      <td>2017-05-16</td>\n",
       "      <td>Investigational Site Number 51, Gent, 9000, Be...</td>\n",
       "      <td>0.044558</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>NONE</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01336660</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Poisoning by Scorpion Sting</td>\n",
       "      <td>BIOLOGICAL: Equine F(ab')2 antivenom|OTHER: In...</td>\n",
       "      <td>Instituto Bioclon S.A. de C.V.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>56</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-07-21</td>\n",
       "      <td>2018-11-15</td>\n",
       "      <td>2018-12-13</td>\n",
       "      <td>CHU Hassan II de FÃ¨s, FÃ¨s, Morocco|HÃ´pital ...</td>\n",
       "      <td>7.279202</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01376167</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Malaria, Vivax</td>\n",
       "      <td>DRUG: Chloroquine 600mg|DRUG: Chloroquine 300m...</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>851</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-04-24</td>\n",
       "      <td>2016-11-18</td>\n",
       "      <td>2018-04-23</td>\n",
       "      <td>GSK Investigational Site, Bandarban, Banglades...</td>\n",
       "      <td>1.969008</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20671</th>\n",
       "      <td>NCT04883333</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>DRUG: LEO 153339|DRUG: Placebo</td>\n",
       "      <td>LEO Pharma</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>108</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-05-17</td>\n",
       "      <td>2022-07-18</td>\n",
       "      <td>2023-04-26</td>\n",
       "      <td>LEO Pharma Investigational Site, Groningen, NZ...</td>\n",
       "      <td>7.693208</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>DOUBLE (PARTICIPANT, INVESTIGATOR)</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20672</th>\n",
       "      <td>NCT02453087</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-Hodgkin's Lymphoma</td>\n",
       "      <td>DRUG: DCDS0780A|DRUG: Rituximab|DRUG: Obinutuz...</td>\n",
       "      <td>Hoffmann-La Roche</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>66</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2015-08-04</td>\n",
       "      <td>2019-07-12</td>\n",
       "      <td>2019-08-29</td>\n",
       "      <td>City of Hope National Medical Center, Duarte, ...</td>\n",
       "      <td>0.199434</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>NONE</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20673</th>\n",
       "      <td>NCT03850587</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Osteoarthritis, Knee</td>\n",
       "      <td>DRUG: Celecoxib 200mg|DRUG: Tramadol 37.5Mg+ C...</td>\n",
       "      <td>Yooyoung Pharmaceutical Co., Ltd.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>261</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-30</td>\n",
       "      <td>2020-09-07</td>\n",
       "      <td>2021-05-11</td>\n",
       "      <td>Dong-A University Hospital., Busan, Korea, Rep...</td>\n",
       "      <td>1.074256</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>DOUBLE (PARTICIPANT, INVESTIGATOR)</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20674</th>\n",
       "      <td>NCT01981187</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Solid Tumor|Hematologic Malignancies</td>\n",
       "      <td>DRUG: LGX818</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>12</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2014-01-14</td>\n",
       "      <td>2015-10-13</td>\n",
       "      <td>2021-03-26</td>\n",
       "      <td>Alabama Oncology St. Vincent's Birmingham, Bir...</td>\n",
       "      <td>0.044077</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>Masking:</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20675</th>\n",
       "      <td>NCT03591887</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Plaque Psoriasis</td>\n",
       "      <td>BIOLOGICAL: ABY-035|BIOLOGICAL: Placebo</td>\n",
       "      <td>Affibody</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>108</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-03-07</td>\n",
       "      <td>2021-12-03</td>\n",
       "      <td>2023-06-08</td>\n",
       "      <td>Rothhaar Studien GmbH, Berlin, 10783, Germany|...</td>\n",
       "      <td>0.133504</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>20676 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        NCT Number Study Status Study Results  \\\n",
       "0      NCT00900809    COMPLETED            NO   \n",
       "1      NCT01113515    COMPLETED           YES   \n",
       "2      NCT01288573    COMPLETED            NO   \n",
       "3      NCT01336660    COMPLETED            NO   \n",
       "4      NCT01376167    COMPLETED           YES   \n",
       "...            ...          ...           ...   \n",
       "20671  NCT04883333    COMPLETED            NO   \n",
       "20672  NCT02453087    COMPLETED            NO   \n",
       "20673  NCT03850587    COMPLETED            NO   \n",
       "20674  NCT01981187   TERMINATED           YES   \n",
       "20675  NCT03591887    COMPLETED            NO   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                                 Acute Myeloid Leukemia   \n",
       "1                                    Diabetic Foot Ulcer   \n",
       "2      Ewing's Sarcoma/Soft Tissue Sarcoma|Neuroblast...   \n",
       "3                            Poisoning by Scorpion Sting   \n",
       "4                                         Malaria, Vivax   \n",
       "...                                                  ...   \n",
       "20671                                 Healthy Volunteers   \n",
       "20672                             Non-Hodgkin's Lymphoma   \n",
       "20673                               Osteoarthritis, Knee   \n",
       "20674               Solid Tumor|Hematologic Malignancies   \n",
       "20675                                   Plaque Psoriasis   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                      BIOLOGICAL: Neukoplastâ„¢ (NK-92)   \n",
       "1      DRUG: Esmolol hydrochloride|DRUG: Esmolol hydr...   \n",
       "2      DRUG: plerixafor|DRUG: plerixafor|DRUG: plerix...   \n",
       "3      BIOLOGICAL: Equine F(ab')2 antivenom|OTHER: In...   \n",
       "4      DRUG: Chloroquine 600mg|DRUG: Chloroquine 300m...   \n",
       "...                                                  ...   \n",
       "20671                     DRUG: LEO 153339|DRUG: Placebo   \n",
       "20672  DRUG: DCDS0780A|DRUG: Rituximab|DRUG: Obinutuz...   \n",
       "20673  DRUG: Celecoxib 200mg|DRUG: Tramadol 37.5Mg+ C...   \n",
       "20674                                       DRUG: LGX818   \n",
       "20675            BIOLOGICAL: ABY-035|BIOLOGICAL: Placebo   \n",
       "\n",
       "                                 Sponsor  Sex                        Age  \\\n",
       "0                      ImmunityBio, Inc.  ALL         ADULT, OLDER_ADULT   \n",
       "1        Novalead Pharma Private Limited  ALL         ADULT, OLDER_ADULT   \n",
       "2              Genzyme, a Sanofi Company  ALL               CHILD, ADULT   \n",
       "3         Instituto Bioclon S.A. de C.V.  ALL                      CHILD   \n",
       "4                        GlaxoSmithKline  ALL  CHILD, ADULT, OLDER_ADULT   \n",
       "...                                  ...  ...                        ...   \n",
       "20671                         LEO Pharma  ALL         ADULT, OLDER_ADULT   \n",
       "20672                  Hoffmann-La Roche  ALL         ADULT, OLDER_ADULT   \n",
       "20673  Yooyoung Pharmaceutical Co., Ltd.  ALL         ADULT, OLDER_ADULT   \n",
       "20674                             Pfizer  ALL         ADULT, OLDER_ADULT   \n",
       "20675                           Affibody  ALL         ADULT, OLDER_ADULT   \n",
       "\n",
       "              Phases  Enrollment  ...  \\\n",
       "0             PHASE1           7  ...   \n",
       "1      PHASE1|PHASE2          44  ...   \n",
       "2      PHASE1|PHASE2          46  ...   \n",
       "3      PHASE2|PHASE3          56  ...   \n",
       "4             PHASE2         851  ...   \n",
       "...              ...         ...  ...   \n",
       "20671         PHASE1         108  ...   \n",
       "20672         PHASE1          66  ...   \n",
       "20673         PHASE2         261  ...   \n",
       "20674         PHASE2          12  ...   \n",
       "20675         PHASE2         108  ...   \n",
       "\n",
       "                                            Study Design Start Date  \\\n",
       "0      Allocation: NA|Intervention Model: SINGLE_GROU... 2014-05-12   \n",
       "1      Allocation: RANDOMIZED|Intervention Model: PAR... 2014-02-20   \n",
       "2      Allocation: RANDOMIZED|Intervention Model: PAR... 2014-03-03   \n",
       "3      Allocation: RANDOMIZED|Intervention Model: PAR... 2018-07-21   \n",
       "4      Allocation: RANDOMIZED|Intervention Model: PAR... 2014-04-24   \n",
       "...                                                  ...        ...   \n",
       "20671  Allocation: RANDOMIZED|Intervention Model: PAR... 2021-05-17   \n",
       "20672  Allocation: NON_RANDOMIZED|Intervention Model:... 2015-08-04   \n",
       "20673  Allocation: RANDOMIZED|Intervention Model: PAR... 2018-08-30   \n",
       "20674  Allocation: NA|Intervention Model: SINGLE_GROU... 2014-01-14   \n",
       "20675  Allocation: RANDOMIZED|Intervention Model: PAR... 2018-03-07   \n",
       "\n",
       "      Completion Date Last Update Posted  \\\n",
       "0          2015-06-02         2022-04-05   \n",
       "1          2015-10-17         2024-05-20   \n",
       "2          2017-05-09         2017-05-16   \n",
       "3          2018-11-15         2018-12-13   \n",
       "4          2016-11-18         2018-04-23   \n",
       "...               ...                ...   \n",
       "20671      2022-07-18         2023-04-26   \n",
       "20672      2019-07-12         2019-08-29   \n",
       "20673      2020-09-07         2021-05-11   \n",
       "20674      2015-10-13         2021-03-26   \n",
       "20675      2021-12-03         2023-06-08   \n",
       "\n",
       "                                               Locations  \\\n",
       "0      UPMC Cancer Center - Hillman Cancer Center, Pi...   \n",
       "1      VA New England Health Care Division, Providenc...   \n",
       "2      Investigational Site Number 51, Gent, 9000, Be...   \n",
       "3      CHU Hassan II de FÃ¨s, FÃ¨s, Morocco|HÃ´pital ...   \n",
       "4      GSK Investigational Site, Bandarban, Banglades...   \n",
       "...                                                  ...   \n",
       "20671  LEO Pharma Investigational Site, Groningen, NZ...   \n",
       "20672  City of Hope National Medical Center, Duarte, ...   \n",
       "20673  Dong-A University Hospital., Busan, Korea, Rep...   \n",
       "20674  Alabama Oncology St. Vincent's Birmingham, Bir...   \n",
       "20675  Rothhaar Studien GmbH, Berlin, 10783, Germany|...   \n",
       "\n",
       "      Study Recruitment Rate      Allocation  Intervention Model  \\\n",
       "0                   0.551598              NA        SINGLE_GROUP   \n",
       "1                   0.443157      RANDOMIZED            PARALLEL   \n",
       "2                   0.044558      RANDOMIZED            PARALLEL   \n",
       "3                   7.279202      RANDOMIZED            PARALLEL   \n",
       "4                   1.969008      RANDOMIZED            PARALLEL   \n",
       "...                      ...             ...                 ...   \n",
       "20671               7.693208      RANDOMIZED            PARALLEL   \n",
       "20672               0.199434  NON_RANDOMIZED            PARALLEL   \n",
       "20673               1.074256      RANDOMIZED            PARALLEL   \n",
       "20674               0.044077              NA        SINGLE_GROUP   \n",
       "20675               0.133504      RANDOMIZED            PARALLEL   \n",
       "\n",
       "                                                 Masking Primary Purpose  \n",
       "0                                                   NONE       TREATMENT  \n",
       "1      TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)       TREATMENT  \n",
       "2                                                   NONE       TREATMENT  \n",
       "3      QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT  \n",
       "4      QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT  \n",
       "...                                                  ...             ...  \n",
       "20671                 DOUBLE (PARTICIPANT, INVESTIGATOR)       TREATMENT  \n",
       "20672                                               NONE       TREATMENT  \n",
       "20673                 DOUBLE (PARTICIPANT, INVESTIGATOR)       TREATMENT  \n",
       "20674                                           Masking:       TREATMENT  \n",
       "20675  QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT  \n",
       "\n",
       "[20676 rows x 22 columns]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "for col in ['Allocation', 'Intervention Model', 'Masking', 'Primary Purpose']:\n",
    "    df[col] = df[col].str.strip()\n",
    "\n",
    "#Remove the prefixes from the columns\n",
    "prefixes_to_remove = [\"Allocation: \", \"Intervention Model: \", \"Masking: \", \"Primary Purpose: \"]\n",
    "for col, prefix in zip(['Allocation', 'Intervention Model', 'Masking', 'Primary Purpose'], prefixes_to_remove):\n",
    "    df[col] = df[col].str.replace(prefix, '', regex=False)\n",
    "\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "277987c0-defa-4710-a95a-83f3da216f9e",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>...</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Recruitment Rate</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>Intervention Model</th>\n",
       "      <th>Masking</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>Allocation_Indexed</th>\n",
       "      <th>Intervention Model_Indexed</th>\n",
       "      <th>Masking_Indexed</th>\n",
       "      <th>Primary Purpose_Indexed</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00900809</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Acute Myeloid Leukemia</td>\n",
       "      <td>BIOLOGICAL: Neukoplastâ„¢ (NK-92)</td>\n",
       "      <td>ImmunityBio, Inc.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>7</td>\n",
       "      <td>...</td>\n",
       "      <td>UPMC Cancer Center - Hillman Cancer Center, Pi...</td>\n",
       "      <td>0.551598</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>NONE</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>1</td>\n",
       "      <td>5</td>\n",
       "      <td>8</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01113515</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Diabetic Foot Ulcer</td>\n",
       "      <td>DRUG: Esmolol hydrochloride|DRUG: Esmolol hydr...</td>\n",
       "      <td>Novalead Pharma Private Limited</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1|PHASE2</td>\n",
       "      <td>44</td>\n",
       "      <td>...</td>\n",
       "      <td>VA New England Health Care Division, Providenc...</td>\n",
       "      <td>0.443157</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>16</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01288573</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Ewing's Sarcoma/Soft Tissue Sarcoma|Neuroblast...</td>\n",
       "      <td>DRUG: plerixafor|DRUG: plerixafor|DRUG: plerix...</td>\n",
       "      <td>Genzyme, a Sanofi Company</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>PHASE1|PHASE2</td>\n",
       "      <td>46</td>\n",
       "      <td>...</td>\n",
       "      <td>Investigational Site Number 51, Gent, 9000, Be...</td>\n",
       "      <td>0.044558</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>NONE</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>8</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01336660</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Poisoning by Scorpion Sting</td>\n",
       "      <td>BIOLOGICAL: Equine F(ab')2 antivenom|OTHER: In...</td>\n",
       "      <td>Instituto Bioclon S.A. de C.V.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>56</td>\n",
       "      <td>...</td>\n",
       "      <td>CHU Hassan II de FÃ¨s, FÃ¨s, Morocco|HÃ´pital ...</td>\n",
       "      <td>7.279202</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>9</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01376167</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Malaria, Vivax</td>\n",
       "      <td>DRUG: Chloroquine 600mg|DRUG: Chloroquine 300m...</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>851</td>\n",
       "      <td>...</td>\n",
       "      <td>GSK Investigational Site, Bandarban, Banglades...</td>\n",
       "      <td>1.969008</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>9</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20671</th>\n",
       "      <td>NCT04883333</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>DRUG: LEO 153339|DRUG: Placebo</td>\n",
       "      <td>LEO Pharma</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>108</td>\n",
       "      <td>...</td>\n",
       "      <td>LEO Pharma Investigational Site, Groningen, NZ...</td>\n",
       "      <td>7.693208</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>DOUBLE (PARTICIPANT, INVESTIGATOR)</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>5</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20672</th>\n",
       "      <td>NCT02453087</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-Hodgkin's Lymphoma</td>\n",
       "      <td>DRUG: DCDS0780A|DRUG: Rituximab|DRUG: Obinutuz...</td>\n",
       "      <td>Hoffmann-La Roche</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>66</td>\n",
       "      <td>...</td>\n",
       "      <td>City of Hope National Medical Center, Duarte, ...</td>\n",
       "      <td>0.199434</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>NONE</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>8</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20673</th>\n",
       "      <td>NCT03850587</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Osteoarthritis, Knee</td>\n",
       "      <td>DRUG: Celecoxib 200mg|DRUG: Tramadol 37.5Mg+ C...</td>\n",
       "      <td>Yooyoung Pharmaceutical Co., Ltd.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>261</td>\n",
       "      <td>...</td>\n",
       "      <td>Dong-A University Hospital., Busan, Korea, Rep...</td>\n",
       "      <td>1.074256</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>DOUBLE (PARTICIPANT, INVESTIGATOR)</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>5</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20674</th>\n",
       "      <td>NCT01981187</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Solid Tumor|Hematologic Malignancies</td>\n",
       "      <td>DRUG: LGX818</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>12</td>\n",
       "      <td>...</td>\n",
       "      <td>Alabama Oncology St. Vincent's Birmingham, Bir...</td>\n",
       "      <td>0.044077</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>Masking:</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>1</td>\n",
       "      <td>5</td>\n",
       "      <td>7</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20675</th>\n",
       "      <td>NCT03591887</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Plaque Psoriasis</td>\n",
       "      <td>BIOLOGICAL: ABY-035|BIOLOGICAL: Placebo</td>\n",
       "      <td>Affibody</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>108</td>\n",
       "      <td>...</td>\n",
       "      <td>Rothhaar Studien GmbH, Berlin, 10783, Germany|...</td>\n",
       "      <td>0.133504</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "      <td>9</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>20676 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        NCT Number Study Status Study Results  \\\n",
       "0      NCT00900809    COMPLETED            NO   \n",
       "1      NCT01113515    COMPLETED           YES   \n",
       "2      NCT01288573    COMPLETED            NO   \n",
       "3      NCT01336660    COMPLETED            NO   \n",
       "4      NCT01376167    COMPLETED           YES   \n",
       "...            ...          ...           ...   \n",
       "20671  NCT04883333    COMPLETED            NO   \n",
       "20672  NCT02453087    COMPLETED            NO   \n",
       "20673  NCT03850587    COMPLETED            NO   \n",
       "20674  NCT01981187   TERMINATED           YES   \n",
       "20675  NCT03591887    COMPLETED            NO   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                                 Acute Myeloid Leukemia   \n",
       "1                                    Diabetic Foot Ulcer   \n",
       "2      Ewing's Sarcoma/Soft Tissue Sarcoma|Neuroblast...   \n",
       "3                            Poisoning by Scorpion Sting   \n",
       "4                                         Malaria, Vivax   \n",
       "...                                                  ...   \n",
       "20671                                 Healthy Volunteers   \n",
       "20672                             Non-Hodgkin's Lymphoma   \n",
       "20673                               Osteoarthritis, Knee   \n",
       "20674               Solid Tumor|Hematologic Malignancies   \n",
       "20675                                   Plaque Psoriasis   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                      BIOLOGICAL: Neukoplastâ„¢ (NK-92)   \n",
       "1      DRUG: Esmolol hydrochloride|DRUG: Esmolol hydr...   \n",
       "2      DRUG: plerixafor|DRUG: plerixafor|DRUG: plerix...   \n",
       "3      BIOLOGICAL: Equine F(ab')2 antivenom|OTHER: In...   \n",
       "4      DRUG: Chloroquine 600mg|DRUG: Chloroquine 300m...   \n",
       "...                                                  ...   \n",
       "20671                     DRUG: LEO 153339|DRUG: Placebo   \n",
       "20672  DRUG: DCDS0780A|DRUG: Rituximab|DRUG: Obinutuz...   \n",
       "20673  DRUG: Celecoxib 200mg|DRUG: Tramadol 37.5Mg+ C...   \n",
       "20674                                       DRUG: LGX818   \n",
       "20675            BIOLOGICAL: ABY-035|BIOLOGICAL: Placebo   \n",
       "\n",
       "                                 Sponsor  Sex                        Age  \\\n",
       "0                      ImmunityBio, Inc.  ALL         ADULT, OLDER_ADULT   \n",
       "1        Novalead Pharma Private Limited  ALL         ADULT, OLDER_ADULT   \n",
       "2              Genzyme, a Sanofi Company  ALL               CHILD, ADULT   \n",
       "3         Instituto Bioclon S.A. de C.V.  ALL                      CHILD   \n",
       "4                        GlaxoSmithKline  ALL  CHILD, ADULT, OLDER_ADULT   \n",
       "...                                  ...  ...                        ...   \n",
       "20671                         LEO Pharma  ALL         ADULT, OLDER_ADULT   \n",
       "20672                  Hoffmann-La Roche  ALL         ADULT, OLDER_ADULT   \n",
       "20673  Yooyoung Pharmaceutical Co., Ltd.  ALL         ADULT, OLDER_ADULT   \n",
       "20674                             Pfizer  ALL         ADULT, OLDER_ADULT   \n",
       "20675                           Affibody  ALL         ADULT, OLDER_ADULT   \n",
       "\n",
       "              Phases  Enrollment  ...  \\\n",
       "0             PHASE1           7  ...   \n",
       "1      PHASE1|PHASE2          44  ...   \n",
       "2      PHASE1|PHASE2          46  ...   \n",
       "3      PHASE2|PHASE3          56  ...   \n",
       "4             PHASE2         851  ...   \n",
       "...              ...         ...  ...   \n",
       "20671         PHASE1         108  ...   \n",
       "20672         PHASE1          66  ...   \n",
       "20673         PHASE2         261  ...   \n",
       "20674         PHASE2          12  ...   \n",
       "20675         PHASE2         108  ...   \n",
       "\n",
       "                                               Locations  \\\n",
       "0      UPMC Cancer Center - Hillman Cancer Center, Pi...   \n",
       "1      VA New England Health Care Division, Providenc...   \n",
       "2      Investigational Site Number 51, Gent, 9000, Be...   \n",
       "3      CHU Hassan II de FÃ¨s, FÃ¨s, Morocco|HÃ´pital ...   \n",
       "4      GSK Investigational Site, Bandarban, Banglades...   \n",
       "...                                                  ...   \n",
       "20671  LEO Pharma Investigational Site, Groningen, NZ...   \n",
       "20672  City of Hope National Medical Center, Duarte, ...   \n",
       "20673  Dong-A University Hospital., Busan, Korea, Rep...   \n",
       "20674  Alabama Oncology St. Vincent's Birmingham, Bir...   \n",
       "20675  Rothhaar Studien GmbH, Berlin, 10783, Germany|...   \n",
       "\n",
       "      Study Recruitment Rate      Allocation Intervention Model  \\\n",
       "0                   0.551598              NA       SINGLE_GROUP   \n",
       "1                   0.443157      RANDOMIZED           PARALLEL   \n",
       "2                   0.044558      RANDOMIZED           PARALLEL   \n",
       "3                   7.279202      RANDOMIZED           PARALLEL   \n",
       "4                   1.969008      RANDOMIZED           PARALLEL   \n",
       "...                      ...             ...                ...   \n",
       "20671               7.693208      RANDOMIZED           PARALLEL   \n",
       "20672               0.199434  NON_RANDOMIZED           PARALLEL   \n",
       "20673               1.074256      RANDOMIZED           PARALLEL   \n",
       "20674               0.044077              NA       SINGLE_GROUP   \n",
       "20675               0.133504      RANDOMIZED           PARALLEL   \n",
       "\n",
       "                                                 Masking Primary Purpose  \\\n",
       "0                                                   NONE       TREATMENT   \n",
       "1      TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)       TREATMENT   \n",
       "2                                                   NONE       TREATMENT   \n",
       "3      QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT   \n",
       "4      QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT   \n",
       "...                                                  ...             ...   \n",
       "20671                 DOUBLE (PARTICIPANT, INVESTIGATOR)       TREATMENT   \n",
       "20672                                               NONE       TREATMENT   \n",
       "20673                 DOUBLE (PARTICIPANT, INVESTIGATOR)       TREATMENT   \n",
       "20674                                           Masking:       TREATMENT   \n",
       "20675  QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT   \n",
       "\n",
       "      Allocation_Indexed  Intervention Model_Indexed Masking_Indexed  \\\n",
       "0                      1                           5               8   \n",
       "1                      3                           3              16   \n",
       "2                      3                           3               8   \n",
       "3                      3                           3               9   \n",
       "4                      3                           3               9   \n",
       "...                  ...                         ...             ...   \n",
       "20671                  3                           3               5   \n",
       "20672                  2                           3               8   \n",
       "20673                  3                           3               5   \n",
       "20674                  1                           5               7   \n",
       "20675                  3                           3               9   \n",
       "\n",
       "      Primary Purpose_Indexed  \n",
       "0                           8  \n",
       "1                           8  \n",
       "2                           8  \n",
       "3                           8  \n",
       "4                           8  \n",
       "...                       ...  \n",
       "20671                       8  \n",
       "20672                       8  \n",
       "20673                       8  \n",
       "20674                       8  \n",
       "20675                       8  \n",
       "\n",
       "[20676 rows x 26 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.preprocessing import LabelEncoder\n",
    "\n",
    "categorical_columns = [\"Allocation\", \"Intervention Model\", \"Masking\", \"Primary Purpose\"]\n",
    "\n",
    "# Create indexed column names for these columns\n",
    "categorical_columns_indexed = [col + \"_Indexed\" for col in categorical_columns]\n",
    "\n",
    "# Apply LabelEncoder to each specified column\n",
    "label_encoders = {}\n",
    "for col, indexed_col in zip(categorical_columns, categorical_columns_indexed):\n",
    "    le = LabelEncoder()\n",
    "    df[indexed_col] = le.fit_transform(df[col])\n",
    "    label_encoders[col] = le  # Save the encoder for inverse transformation if needed\n",
    "\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "496cfdce-abf4-49c5-900d-e76ece817779",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Frequency of values in 'Allocation':\n",
      "\n",
      "Allocation\n",
      "RANDOMIZED        12828\n",
      "NA                 4834\n",
      "NON_RANDOMIZED     2953\n",
      "Allocation:          61\n",
      "Name: count, dtype: int64\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Frequency of values in 'Intervention Model':\n",
      "\n",
      "Intervention Model\n",
      "PARALLEL               10743\n",
      "SINGLE_GROUP            5076\n",
      "SEQUENTIAL              2505\n",
      "CROSSOVER               2259\n",
      "FACTORIAL                 64\n",
      "Intervention Model:       29\n",
      "Name: count, dtype: int64\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Frequency of values in 'Masking':\n",
      "\n",
      "Masking\n",
      "NONE                                                                       11151\n",
      "QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)     4100\n",
      "DOUBLE (PARTICIPANT, INVESTIGATOR)                                          2857\n",
      "TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)                           1041\n",
      "TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)                        619\n",
      "SINGLE (PARTICIPANT)                                                         348\n",
      "SINGLE (OUTCOMES_ASSESSOR)                                                   220\n",
      "DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)                                       89\n",
      "DOUBLE (PARTICIPANT, CARE_PROVIDER)                                           88\n",
      "SINGLE (INVESTIGATOR)                                                         49\n",
      "TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)                        46\n",
      "DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)                                      31\n",
      "DOUBLE                                                                        11\n",
      "SINGLE (CARE_PROVIDER)                                                         8\n",
      "Masking:                                                                       7\n",
      "TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)                        5\n",
      "DOUBLE (CARE_PROVIDER, INVESTIGATOR)                                           3\n",
      "DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)                                      2\n",
      "SINGLE                                                                         1\n",
      "Name: count, dtype: int64\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Frequency of values in 'Primary Purpose':\n",
      "\n",
      "Primary Purpose\n",
      "TREATMENT                   16326\n",
      "OTHER                        1437\n",
      "BASIC_SCIENCE                1276\n",
      "PREVENTION                   1264\n",
      "DIAGNOSTIC                    196\n",
      "SUPPORTIVE_CARE               100\n",
      "HEALTH_SERVICES_RESEARCH       43\n",
      "SCREENING                      25\n",
      "DEVICE_FEASIBILITY              9\n",
      "Name: count, dtype: int64\n",
      "\n",
      "--------------------------------------------------\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# List of the columns you want to get the frequency for\n",
    "columns_to_check = [\"Allocation\", \"Intervention Model\", \"Masking\", \"Primary Purpose\"]\n",
    "\n",
    "# Apply value_counts() to each of the specified columns and store the results\n",
    "for col in columns_to_check:\n",
    "    print(f\"Frequency of values in '{col}':\\n\")\n",
    "    print(df[col].value_counts())\n",
    "    print(\"\\n\" + \"-\"*50 + \"\\n\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "1639c263-420e-41b4-8b05-3854bb662b52",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# List of the columns to check\n",
    "columns_to_check = [\"Allocation\", \"Intervention Model\", \"Masking\", \"Primary Purpose\"]\n",
    "\n",
    "# Loop through each column and filter out rows where the value is equal to the column name itself\n",
    "for col in columns_to_check:\n",
    "    df = df[df[col] != col + \":\"]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "e554af36-3bbe-4fa6-9ddf-4af3ba19b77b",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Frequency of values in 'Allocation':\n",
      "\n",
      "Allocation\n",
      "RANDOMIZED        12815\n",
      "NA                 4827\n",
      "NON_RANDOMIZED     2944\n",
      "Name: count, dtype: int64\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Frequency of values in 'Intervention Model':\n",
      "\n",
      "Intervention Model\n",
      "PARALLEL        10734\n",
      "SINGLE_GROUP     5074\n",
      "SEQUENTIAL       2459\n",
      "CROSSOVER        2255\n",
      "FACTORIAL          64\n",
      "Name: count, dtype: int64\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Frequency of values in 'Masking':\n",
      "\n",
      "Masking\n",
      "NONE                                                                       11074\n",
      "QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)     4100\n",
      "DOUBLE (PARTICIPANT, INVESTIGATOR)                                          2854\n",
      "TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)                           1040\n",
      "TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)                        617\n",
      "SINGLE (PARTICIPANT)                                                         348\n",
      "SINGLE (OUTCOMES_ASSESSOR)                                                   220\n",
      "DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)                                       89\n",
      "DOUBLE (PARTICIPANT, CARE_PROVIDER)                                           88\n",
      "SINGLE (INVESTIGATOR)                                                         49\n",
      "TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)                        46\n",
      "DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)                                      31\n",
      "DOUBLE                                                                        11\n",
      "SINGLE (CARE_PROVIDER)                                                         8\n",
      "TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)                        5\n",
      "DOUBLE (CARE_PROVIDER, INVESTIGATOR)                                           3\n",
      "DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)                                      2\n",
      "SINGLE                                                                         1\n",
      "Name: count, dtype: int64\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Frequency of values in 'Primary Purpose':\n",
      "\n",
      "Primary Purpose\n",
      "TREATMENT                   16264\n",
      "OTHER                        1425\n",
      "BASIC_SCIENCE                1264\n",
      "PREVENTION                   1263\n",
      "DIAGNOSTIC                    194\n",
      "SUPPORTIVE_CARE               100\n",
      "HEALTH_SERVICES_RESEARCH       43\n",
      "SCREENING                      24\n",
      "DEVICE_FEASIBILITY              9\n",
      "Name: count, dtype: int64\n",
      "\n",
      "--------------------------------------------------\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# List of the columns you want to get the frequency for\n",
    "columns_to_check = [\"Allocation\", \"Intervention Model\", \"Masking\", \"Primary Purpose\"]\n",
    "\n",
    "# Apply value_counts() to each of the specified columns and store the results\n",
    "for col in columns_to_check:\n",
    "    print(f\"Frequency of values in '{col}':\\n\")\n",
    "    print(df[col].value_counts())\n",
    "    print(\"\\n\" + \"-\"*50 + \"\\n\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "57b4c88e-86b7-4de4-a331-d7741433bbbf",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv(\"final_dataset.csv\", index = False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "c0d2f785",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "        NCT Number Study Status Study Results  \\\n",
      "963    NCT02281630    COMPLETED            NO   \n",
      "6185   NCT03338556    COMPLETED           YES   \n",
      "7258   NCT03478787    COMPLETED           YES   \n",
      "13007  NCT04418388    COMPLETED            NO   \n",
      "13779  NCT04543370    COMPLETED            NO   \n",
      "16124  NCT04972045    COMPLETED            NO   \n",
      "16894  NCT05125549    COMPLETED            NO   \n",
      "\n",
      "                                    Conditions  \\\n",
      "963                       Chronic Constipation   \n",
      "6185   Viral Upper Respiratory Tract Infection   \n",
      "7258                                 Psoriasis   \n",
      "13007                        Healthy Volunteer   \n",
      "13779                                  Healthy   \n",
      "16124                   Healthy Adult Subjects   \n",
      "16894                         Pharmacokinetics   \n",
      "\n",
      "                                           Interventions  \\\n",
      "963                         DRUG: KWA-0711|DRUG: Placebo   \n",
      "6185                       DRUG: PrEP-001|OTHER: Placebo   \n",
      "7258                DRUG: risankizumab|DRUG: secukinumab   \n",
      "13007       DRUG: PBK-1801|DRUG: PBK-1801|DRUG: PBK-1801   \n",
      "13779  DRUG: Edasalonexent 2000 mg TID|DRUG: Midazola...   \n",
      "16124          DRUG: CuminUP60Â®|DRUG: Curcumin capsules   \n",
      "16894  DRUG: Ð¡lopidogrel bisulfate film-coated table...   \n",
      "\n",
      "                                             Sponsor  Sex  \\\n",
      "963                  Kissei Pharmaceutical Co., Ltd.  ALL   \n",
      "6185                           Prep Biopharm Limited  NaN   \n",
      "7258                                          AbbVie  NaN   \n",
      "13007                       Pharmbio Korea Co., Ltd.  NaN   \n",
      "13779                      Catabasis Pharmaceuticals  NaN   \n",
      "16124  The Affiliated Hospital of Qingdao University  NaN   \n",
      "16894                   Joint Stock Company \"Farmak\"  NaN   \n",
      "\n",
      "                             Age  Phases  Enrollment  ...  \\\n",
      "963           ADULT, OLDER_ADULT  PHASE2         388  ...   \n",
      "6185                       ADULT  PHASE2         102  ...   \n",
      "7258          ADULT, OLDER_ADULT  PHASE3         327  ...   \n",
      "13007  CHILD, ADULT, OLDER_ADULT  PHASE1          36  ...   \n",
      "13779                      ADULT  PHASE1          26  ...   \n",
      "16124                      ADULT  PHASE1          12  ...   \n",
      "16894                      ADULT  PHASE1          48  ...   \n",
      "\n",
      "                                               Locations  \\\n",
      "963                 Tokyo and Other Japanese City, Japan   \n",
      "6185   hVIVO Services Limited, QMB Innovation Centre,...   \n",
      "7258   Advanced Research Associates - Glendale /ID# 2...   \n",
      "13007  Seoul National University Hospital, Seoul, Kor...   \n",
      "13779  Celerion Clinical Research Unit, Tempe, Arizon...   \n",
      "16124  Phase I Clinical Research Center, Qingdao, Sha...   \n",
      "16894  Clinical and Diagnostics Center of National Un...   \n",
      "\n",
      "      Study Recruitment Rate      Allocation Intervention Model  \\\n",
      "963                60.521368      RANDOMIZED           PARALLEL   \n",
      "6185               17.528249      RANDOMIZED           PARALLEL   \n",
      "7258                0.205875      RANDOMIZED           PARALLEL   \n",
      "13007              18.250000  NON_RANDOMIZED         SEQUENTIAL   \n",
      "13779              14.645062  NON_RANDOMIZED       SINGLE_GROUP   \n",
      "16124               4.932432      RANDOMIZED          CROSSOVER   \n",
      "16894              31.739130      RANDOMIZED          CROSSOVER   \n",
      "\n",
      "                                                 Masking  \\\n",
      "963    QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...   \n",
      "6185   QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...   \n",
      "7258                          SINGLE (OUTCOMES_ASSESSOR)   \n",
      "13007                                               NONE   \n",
      "13779                                               NONE   \n",
      "16124                                               NONE   \n",
      "16894                                               NONE   \n",
      "\n",
      "                Primary Purpose Allocation_Indexed  \\\n",
      "963                   TREATMENT                  3   \n",
      "6185                 PREVENTION                  3   \n",
      "7258                  TREATMENT                  3   \n",
      "13007                 TREATMENT                  2   \n",
      "13779  HEALTH_SERVICES_RESEARCH                  2   \n",
      "16124                PREVENTION                  3   \n",
      "16894                     OTHER                  3   \n",
      "\n",
      "       Intervention Model_Indexed Masking_Indexed Primary Purpose_Indexed  \n",
      "963                             3               9                       8  \n",
      "6185                            3               9                       5  \n",
      "7258                            3              13                       8  \n",
      "13007                           4               8                       8  \n",
      "13779                           5               8                       3  \n",
      "16124                           0               8                       5  \n",
      "16894                           0               8                       4  \n",
      "\n",
      "[7 rows x 26 columns]\n"
     ]
    }
   ],
   "source": [
    "rows_with_null = df[df.isnull().any(axis=1)]\n",
    "print(rows_with_null)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "e560f0fa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                    0\n",
       "Study Status                  0\n",
       "Study Results                 0\n",
       "Conditions                    0\n",
       "Interventions                 0\n",
       "Sponsor                       0\n",
       "Sex                           6\n",
       "Age                           0\n",
       "Phases                        0\n",
       "Enrollment                    0\n",
       "Funder Type                   0\n",
       "Study Type                    0\n",
       "Study Design                  0\n",
       "Start Date                    0\n",
       "Completion Date               1\n",
       "Last Update Posted            0\n",
       "Locations                     0\n",
       "Study Recruitment Rate        0\n",
       "Allocation                    0\n",
       "Intervention Model            0\n",
       "Masking                       0\n",
       "Primary Purpose               0\n",
       "Allocation_Indexed            0\n",
       "Intervention Model_Indexed    0\n",
       "Masking_Indexed               0\n",
       "Primary Purpose_Indexed       0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "682afc84",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "     NCT Number Study Status Study Results  \\\n",
      "42  NCT01902225    COMPLETED            NO   \n",
      "43  NCT01905592   TERMINATED           YES   \n",
      "44  NCT01915303   TERMINATED           YES   \n",
      "45  NCT01920711    COMPLETED           YES   \n",
      "46  NCT01923168    COMPLETED           YES   \n",
      "47  NCT01924169   TERMINATED           YES   \n",
      "48  NCT01930162    COMPLETED           YES   \n",
      "49  NCT01934361    COMPLETED            NO   \n",
      "\n",
      "                                           Conditions  \\\n",
      "42        Lymphoma|T-Cell Lymphoma|Cutaneous Lymphoma   \n",
      "43  Neoplasms, Breast|Carcinoma of Breast|Human Ep...   \n",
      "44                                   Cushings Disease   \n",
      "45     Heart Failure With Preserved Ejection Fraction   \n",
      "46                                      Breast Cancer   \n",
      "47                               Hematologic Disorder   \n",
      "48  Single Umbilical Cord Blood Transplantation|No...   \n",
      "49                  Recurrent Glioblastoma Multiforme   \n",
      "\n",
      "                                        Interventions  \\\n",
      "42                          DRUG: Istodax|DRUG: Doxil   \n",
      "43           DRUG: niraparib|DRUG: Physician's choice   \n",
      "44      DRUG: Pasireotide with or without cabergoline   \n",
      "45                       DRUG: LCZ696|DRUG: Valsartan   \n",
      "46     DRUG: alpelisib|DRUG: buparlisib|DRUG: Placebo   \n",
      "47  DRUG: Lenalidomide|BIOLOGICAL: Influenza Vacci...   \n",
      "48                                       DRUG: HSC835   \n",
      "49  DRUG: buparlisib|DRUG: carboplatin|DRUG: lomus...   \n",
      "\n",
      "                        Sponsor     Sex                        Age  Phases  \\\n",
      "42                    Weiyun Ai     ALL         ADULT, OLDER_ADULT  PHASE1   \n",
      "43                 Tesaro, Inc.     ALL         ADULT, OLDER_ADULT  PHASE3   \n",
      "44     Novartis Pharmaceuticals     ALL         ADULT, OLDER_ADULT  PHASE2   \n",
      "45     Novartis Pharmaceuticals     ALL         ADULT, OLDER_ADULT  PHASE3   \n",
      "46     Novartis Pharmaceuticals  FEMALE         ADULT, OLDER_ADULT  PHASE2   \n",
      "47  M.D. Anderson Cancer Center     ALL         ADULT, OLDER_ADULT  PHASE2   \n",
      "48     Novartis Pharmaceuticals     ALL  CHILD, ADULT, OLDER_ADULT  PHASE2   \n",
      "49     Novartis Pharmaceuticals     ALL         ADULT, OLDER_ADULT  PHASE1   \n",
      "\n",
      "    Enrollment  ...                                          Locations  \\\n",
      "42          24  ...  University of California, San Francisco, San F...   \n",
      "43         216  ...  GSK Investigational Site, Tucson, Arizona, 857...   \n",
      "44          68  ...  University of Alabama at Birmingham The Kirkli...   \n",
      "45        4822  ...  Novartis Investigative Site, Huntsville, Alaba...   \n",
      "46         340  ...  University of Alabama at Birmingham/ Kirklin C...   \n",
      "47           3  ...  University of Texas MD Anderson Cancer Center,...   \n",
      "48           9  ...  Novartis Investigative Site, Minneapolis, Minn...   \n",
      "49          35  ...  Barrow Neurological Insitute St. Joseph's Hosp...   \n",
      "\n",
      "   Study Recruitment Rate  Allocation Intervention Model  \\\n",
      "42               0.163677          NA       SINGLE_GROUP   \n",
      "43               0.022562  RANDOMIZED           PARALLEL   \n",
      "44               0.035519          NA       SINGLE_GROUP   \n",
      "45               0.154450  RANDOMIZED           PARALLEL   \n",
      "46               0.097835  RANDOMIZED           PARALLEL   \n",
      "47               0.111280          NA       SINGLE_GROUP   \n",
      "48               0.395592          NA       SINGLE_GROUP   \n",
      "49               0.088421  RANDOMIZED           PARALLEL   \n",
      "\n",
      "                                              Masking Primary Purpose  \\\n",
      "42                                               NONE       TREATMENT   \n",
      "43                                               NONE       TREATMENT   \n",
      "44                                               NONE       TREATMENT   \n",
      "45                 DOUBLE (PARTICIPANT, INVESTIGATOR)       TREATMENT   \n",
      "46  TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)       TREATMENT   \n",
      "47                                               NONE           OTHER   \n",
      "48                                               NONE   BASIC_SCIENCE   \n",
      "49                                               NONE       TREATMENT   \n",
      "\n",
      "   Allocation_Indexed  Intervention Model_Indexed Masking_Indexed  \\\n",
      "42                  1                           5               8   \n",
      "43                  3                           3               8   \n",
      "44                  1                           5               8   \n",
      "45                  3                           3               5   \n",
      "46                  3                           3              16   \n",
      "47                  1                           5               8   \n",
      "48                  1                           5               8   \n",
      "49                  3                           3               8   \n",
      "\n",
      "   Primary Purpose_Indexed  \n",
      "42                       8  \n",
      "43                       8  \n",
      "44                       8  \n",
      "45                       8  \n",
      "46                       8  \n",
      "47                       4  \n",
      "48                       0  \n",
      "49                       8  \n",
      "\n",
      "[8 rows x 26 columns]\n"
     ]
    }
   ],
   "source": [
    "print(df.iloc[42:50])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "aa08d4e2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0        ALL\n",
      "1        ALL\n",
      "2        ALL\n",
      "3        ALL\n",
      "4        ALL\n",
      "        ... \n",
      "20670    ALL\n",
      "20671    ALL\n",
      "20672    ALL\n",
      "20673    ALL\n",
      "20675    ALL\n",
      "Name: Sex, Length: 20586, dtype: object\n"
     ]
    }
   ],
   "source": [
    "df['Sex'] = df['Sex'].fillna('ALL')\n",
    "\n",
    "\n",
    "\n",
    "# Display the updated column to verify\n",
    "print(df['Sex'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "555befe0",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                    0\n",
       "Study Status                  0\n",
       "Study Results                 0\n",
       "Conditions                    0\n",
       "Interventions                 0\n",
       "Sponsor                       0\n",
       "Sex                           0\n",
       "Age                           0\n",
       "Phases                        0\n",
       "Enrollment                    0\n",
       "Funder Type                   0\n",
       "Study Type                    0\n",
       "Study Design                  0\n",
       "Start Date                    0\n",
       "Completion Date               1\n",
       "Last Update Posted            0\n",
       "Locations                     0\n",
       "Study Recruitment Rate        0\n",
       "Allocation                    0\n",
       "Intervention Model            0\n",
       "Masking                       0\n",
       "Primary Purpose               0\n",
       "Allocation_Indexed            0\n",
       "Intervention Model_Indexed    0\n",
       "Masking_Indexed               0\n",
       "Primary Purpose_Indexed       0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "e6344b8e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.dropna(subset=['Completion Date'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "1ac12b6e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                    0\n",
       "Study Status                  0\n",
       "Study Results                 0\n",
       "Conditions                    0\n",
       "Interventions                 0\n",
       "Sponsor                       0\n",
       "Sex                           0\n",
       "Age                           0\n",
       "Phases                        0\n",
       "Enrollment                    0\n",
       "Funder Type                   0\n",
       "Study Type                    0\n",
       "Study Design                  0\n",
       "Start Date                    0\n",
       "Completion Date               0\n",
       "Last Update Posted            0\n",
       "Locations                     0\n",
       "Study Recruitment Rate        0\n",
       "Allocation                    0\n",
       "Intervention Model            0\n",
       "Masking                       0\n",
       "Primary Purpose               0\n",
       "Allocation_Indexed            0\n",
       "Intervention Model_Indexed    0\n",
       "Masking_Indexed               0\n",
       "Primary Purpose_Indexed       0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "60333d13",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv(\"final_dataset_1.csv\", index = False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "e9a348a3",
   "metadata": {},
   "outputs": [],
   "source": [
    "data = pd.read_csv(\"final_dataset_1.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "3f39d4ce",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                       0\n",
       "Study Status                     0\n",
       "Study Results                    0\n",
       "Conditions                       0\n",
       "Interventions                    0\n",
       "Sponsor                          0\n",
       "Sex                              0\n",
       "Age                              0\n",
       "Phases                           0\n",
       "Enrollment                       0\n",
       "Funder Type                      0\n",
       "Study Type                       0\n",
       "Study Design                     0\n",
       "Start Date                       0\n",
       "Completion Date                  0\n",
       "Last Update Posted               0\n",
       "Locations                        0\n",
       "Study Recruitment Rate           0\n",
       "Allocation                    4827\n",
       "Intervention Model               0\n",
       "Masking                          0\n",
       "Primary Purpose                  0\n",
       "Allocation_Indexed               0\n",
       "Intervention Model_Indexed       0\n",
       "Masking_Indexed                  0\n",
       "Primary Purpose_Indexed          0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "7c009430",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "        NCT Number Study Status Study Results  \\\n",
      "0      NCT00900809    COMPLETED            NO   \n",
      "1      NCT01113515    COMPLETED           YES   \n",
      "2      NCT01288573    COMPLETED            NO   \n",
      "3      NCT01336660    COMPLETED            NO   \n",
      "4      NCT01376167    COMPLETED           YES   \n",
      "...            ...          ...           ...   \n",
      "20580  NCT04229433    COMPLETED            NO   \n",
      "20581  NCT04883333    COMPLETED            NO   \n",
      "20582  NCT02453087    COMPLETED            NO   \n",
      "20583  NCT03850587    COMPLETED            NO   \n",
      "20584  NCT03591887    COMPLETED            NO   \n",
      "\n",
      "                                              Conditions  \\\n",
      "0                                 Acute Myeloid Leukemia   \n",
      "1                                    Diabetic Foot Ulcer   \n",
      "2      Ewing's Sarcoma/Soft Tissue Sarcoma|Neuroblast...   \n",
      "3                            Poisoning by Scorpion Sting   \n",
      "4                                         Malaria, Vivax   \n",
      "...                                                  ...   \n",
      "20580                                           Thrombus   \n",
      "20581                                 Healthy Volunteers   \n",
      "20582                             Non-Hodgkin's Lymphoma   \n",
      "20583                               Osteoarthritis, Knee   \n",
      "20584                                   Plaque Psoriasis   \n",
      "\n",
      "                                           Interventions  \\\n",
      "0                      BIOLOGICAL: Neukoplastâ„¢ (NK-92)   \n",
      "1      DRUG: Esmolol hydrochloride|DRUG: Esmolol hydr...   \n",
      "2      DRUG: plerixafor|DRUG: plerixafor|DRUG: plerix...   \n",
      "3      BIOLOGICAL: Equine F(ab')2 antivenom|OTHER: In...   \n",
      "4      DRUG: Chloroquine 600mg|DRUG: Chloroquine 300m...   \n",
      "...                                                  ...   \n",
      "20580                 DRUG: SHR2285 tablet|DRUG: Placebo   \n",
      "20581                     DRUG: LEO 153339|DRUG: Placebo   \n",
      "20582  DRUG: DCDS0780A|DRUG: Rituximab|DRUG: Obinutuz...   \n",
      "20583  DRUG: Celecoxib 200mg|DRUG: Tramadol 37.5Mg+ C...   \n",
      "20584            BIOLOGICAL: ABY-035|BIOLOGICAL: Placebo   \n",
      "\n",
      "                                  Sponsor  Sex                        Age  \\\n",
      "0                       ImmunityBio, Inc.  ALL         ADULT, OLDER_ADULT   \n",
      "1         Novalead Pharma Private Limited  ALL         ADULT, OLDER_ADULT   \n",
      "2               Genzyme, a Sanofi Company  ALL               CHILD, ADULT   \n",
      "3          Instituto Bioclon S.A. de C.V.  ALL                      CHILD   \n",
      "4                         GlaxoSmithKline  ALL  CHILD, ADULT, OLDER_ADULT   \n",
      "...                                   ...  ...                        ...   \n",
      "20580  Jiangsu HengRui Medicine Co., Ltd.  ALL                      ADULT   \n",
      "20581                          LEO Pharma  ALL         ADULT, OLDER_ADULT   \n",
      "20582                   Hoffmann-La Roche  ALL         ADULT, OLDER_ADULT   \n",
      "20583   Yooyoung Pharmaceutical Co., Ltd.  ALL         ADULT, OLDER_ADULT   \n",
      "20584                            Affibody  ALL         ADULT, OLDER_ADULT   \n",
      "\n",
      "              Phases  Enrollment  ... Intervention Model  \\\n",
      "0             PHASE1           7  ...       SINGLE_GROUP   \n",
      "1      PHASE1|PHASE2          44  ...           PARALLEL   \n",
      "2      PHASE1|PHASE2          46  ...           PARALLEL   \n",
      "3      PHASE2|PHASE3          56  ...           PARALLEL   \n",
      "4             PHASE2         851  ...           PARALLEL   \n",
      "...              ...         ...  ...                ...   \n",
      "20580         PHASE1          36  ...           PARALLEL   \n",
      "20581         PHASE1         108  ...           PARALLEL   \n",
      "20582         PHASE1          66  ...           PARALLEL   \n",
      "20583         PHASE2         261  ...           PARALLEL   \n",
      "20584         PHASE2         108  ...           PARALLEL   \n",
      "\n",
      "                                                 Masking Primary Purpose  \\\n",
      "0                                                   NONE       TREATMENT   \n",
      "1      TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)       TREATMENT   \n",
      "2                                                   NONE       TREATMENT   \n",
      "3      QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT   \n",
      "4      QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT   \n",
      "...                                                  ...             ...   \n",
      "20580                               SINGLE (PARTICIPANT)       TREATMENT   \n",
      "20581                 DOUBLE (PARTICIPANT, INVESTIGATOR)       TREATMENT   \n",
      "20582                                               NONE       TREATMENT   \n",
      "20583                 DOUBLE (PARTICIPANT, INVESTIGATOR)       TREATMENT   \n",
      "20584  QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTI...       TREATMENT   \n",
      "\n",
      "      Allocation_Indexed Intervention Model_Indexed Masking_Indexed  \\\n",
      "0                      1                          5               8   \n",
      "1                      3                          3              16   \n",
      "2                      3                          3               8   \n",
      "3                      3                          3               9   \n",
      "4                      3                          3               9   \n",
      "...                  ...                        ...             ...   \n",
      "20580                  3                          3              14   \n",
      "20581                  3                          3               5   \n",
      "20582                  2                          3               8   \n",
      "20583                  3                          3               5   \n",
      "20584                  3                          3               9   \n",
      "\n",
      "      Primary Purpose_Indexed  Age_Encoded Sex_Encoded Phases_Encoded  \n",
      "0                           8          101         100            100  \n",
      "1                           8          101         100            110  \n",
      "2                           8          110         100            110  \n",
      "3                           8          010         100            011  \n",
      "4                           8          111         100            010  \n",
      "...                       ...          ...         ...            ...  \n",
      "20580                       8          100         100            100  \n",
      "20581                       8          101         100            100  \n",
      "20582                       8          101         100            100  \n",
      "20583                       8          101         100            010  \n",
      "20584                       8          101         100            010  \n",
      "\n",
      "[20585 rows x 29 columns]\n"
     ]
    }
   ],
   "source": [
    "# Create DataFrame\n",
    "df = pd.DataFrame(data)\n",
    "\n",
    "def get_unique_values(column):\n",
    "    unique_values = set()\n",
    "    for entry in df[column].dropna():\n",
    "        unique_values.update(map(str.strip, str(entry).replace(\",\", \"|\").split(\"|\")))\n",
    "    return sorted(unique_values)  # Sort for consistent encoding\n",
    "\n",
    "# Extract unique values for each column\n",
    "unique_age = get_unique_values(\"Age\")\n",
    "unique_sex = get_unique_values(\"Sex\")\n",
    "unique_phases = get_unique_values(\"Phases\")\n",
    "\n",
    "# Function to encode a single column based on unique values\n",
    "def encode_column(row, unique_values, column_name):\n",
    "    values = set(map(str.strip, str(row[column_name]).replace(\",\", \"|\").split(\"|\")))\n",
    "    return ''.join(['1' if val in values else '0' for val in unique_values])\n",
    "\n",
    "# Apply encoding to each column and create separate encoded columns\n",
    "df[\"Age_Encoded\"] = df.apply(lambda row: encode_column(row, unique_age, \"Age\"), axis=1)\n",
    "df[\"Sex_Encoded\"] = df.apply(lambda row: encode_column(row, unique_sex, \"Sex\"), axis=1)\n",
    "df[\"Phases_Encoded\"] = df.apply(lambda row: encode_column(row, unique_phases, \"Phases\"), axis=1)\n",
    "\n",
    "# Output the resulting DataFrame\n",
    "print(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "94c5be91",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv(\"final_dataset.csv\", index = False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e08b9d8a",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
